Fluocinonide NDC 50090-1784

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-1784Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-1784Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-1784-0	50090178400	1 TUBE in 1 CARTON (50090-1784-0) / 30 g in 1 TUBEMarketed from Apr 17, 2015

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluocinonide
Generic name (nonproprietary): fluocinonide
Active ingredients: Fluocinonide — .5 mg/g
Dosage form: Cream
Route: Topical
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 072488
Marketing start: Sep 30, 1990
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 50090-1784_d04a497f-2bc7-414e-a490-c6938647f1c0SPL ID d04a497f-2bc7-414e-a490-c6938647f1c0SPL set ID ce75f0e1-c536-40ad-b77f-2e3ec29caeb7RxCUI 103456UNII 2W4A77YPAN
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090178400 followed by a unit qualifier and the quantity

Package 50090-1784-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 6, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE The topical corticosteriods are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 072488

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 072488
Product	Strength	Form · route	Labeler	Product NDC
Fluocinonide	Fluocinonide .5 mg/g	CreamTopical	Teva Pharmaceuticals USA, Inc.	0093-0262
Fluocinonide	Fluocinonide .5 mg/g	CreamTopical	NuCare Pharmaceuticals, Inc.	66267-973